INTEGRA LIFESCIENCES HOLDINGS CORP 10-Q

ITEM 5. OTHER INFORMATION 46 Table of Contents Not applicable. ITEM 6. EXHIBITS Reference is hereby made to the Exhibit Index on page 49 . 47 Table of Contents SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. INTEGRA LIFESCIENCES HOLDINGS CORPORATION Date: October 29, 2020 /s/ Peter J. Arduini Peter J. Arduini President and Chief Executive Officer (Principal Executive Officer) Date: October 29, 2020 /s/ Carrie L. Anderson Carrie L. Anderson Executive Vice President and Chief Financial Officer (Principal Financial Officer) Date: October 29, 2020 /s/ Jeffrey A. Mosebrook Jeffrey A. Mosebrook Senior Vice President, Finance (Principal Accounting Officer) 48 Table of Contents Exhibits *2.1 Put Option Agreement, dated September 29, 2020, between the Company and certain of its subsidiaries and Smith & Nephew USD Limited, a subsidiary of Smith+Nephew (including the Purchase and Sale Agreement attached as Appendix 1 thereto) *31.1 Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *31.2 Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *32.1 Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 *32.2 Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 *†101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. *†101.SCH XBRL Taxonomy Extension Schema Document *†101.CAL XBRL Taxonomy Extension Calculation Linkbase Document *†101.DEF XBRL Definition Linkbase Document *†101.LAB XBRL Taxonomy Extension Labels Linkbase Document *†101.PRE XBRL Taxonomy Extension Presentation Linkbase Document * Filed herewith # Indicates a management contract or compensatory plan or arrangement. † The financial information of Integra LifeSciences Holdings Corporation Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 filed on October 29, 2020 formatted in XBRL (Extensible Business Reporting Language): (i) the Condensed Consolidated Statements of Operations and Comprehensive Income, (ii) the Condensed Consolidated Balance Sheets, (iii) Parenthetical Data to the Condensed Consolidated Balance Sheets, (iv) the Condensed Consolidated Statements of Cash Flows, and (v) Notes to Condensed Consolidated Financial Statements, is furnished electronically herewith. 49